Notably, the highest expression levels were detected in U251CL and U87 glioma lines, while it was lower in others such as SU-DIPG36GL suggesting a possible correlation between EphA3 expression levels and the efficacy of targeted CAR T cell therapies. This evidence concerns the gene EPHA3 and glioma.